Division of Newborn Medicine, Department of Pediatrics, Washington University in St Louis, St. Louis, MO.
Division of Neonatology, Department of Pediatrics, University of Washington, Seattle, WA.
J Pediatr. 2024 Mar;266:113853. doi: 10.1016/j.jpeds.2023.113853. Epub 2023 Nov 23.
To determine if time to reaching target temperature (TT) is associated with death or neurodevelopmental impairment (NDI) at 2 years of age in infants with hypoxic-ischemic encephalopathy (HIE).
Newborn infants ≥36 weeks of gestation diagnosed with moderate or severe HIE and treated with therapeutic hypothermia were stratified based on time at which TT was reached, defined as early (ie, ≤4 hours of age) or late (>4 hours of age). Primary outcomes were death or NDI. Secondary outcomes included neurodevelopmental assessment with Bayley Scales of Infant and Toddler Development, third edition (BSID-III) at age 2.
Among 500 infants, the median time to reaching TT was 4.3 hours (IWR, 3.2-5.7 hours). Infants in early TT group (n = 211 [42%]) compared with the late TT group (n = 289 [58%]) were more likely to be inborn (23% vs 13%; P < .001) and have severe HIE (28% vs 19%; P = .03). The early and late TT groups did not differ in the primary outcome of death or any NDI (adjusted RR, 1.05; 95% CI, 0.85-0.30; P = .62). Among survivors, neurodevelopmental outcomes did not differ significantly in the 2 groups (adjusted mean difference in Bayley Scales of Infant Development-III scores: cognitive, -2.8 [95% CI, -6.1 to 0.5], language -3.3 [95% CI, -7.4 to 0.8], and motor -3.5 [95% CI, -7.3 to 0.3]).
In infants with HIE, time to reach TT is not independently associated with risk of death or NDI at age 2 years. Among survivors, developmental outcomes are similar between those who reached TT at <4 and ≥4 hours of age.
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL); NCT02811263; https://beta.
gov/study/NCT02811263.
确定对于患有缺氧缺血性脑病(HIE)的婴儿,达到目标体温(TT)的时间与 2 岁时的死亡或神经发育障碍(NDI)是否有关。
本研究对胎龄≥36 周、被诊断患有中重度 HIE 并接受治疗性低温治疗的新生儿进行分层,根据达到 TT 的时间进行分层,定义为早期(即≤4 小时)或晚期(>4 小时)。主要结局为死亡或 NDI。次要结局包括在 2 岁时使用贝利婴幼儿发展量表第三版(BSID-III)进行神经发育评估。
在 500 名婴儿中,达到 TT 的中位数时间为 4.3 小时(IWR,3.2-5.7 小时)。与晚期 TT 组(n=289 [58%])相比,早期 TT 组(n=211 [42%])更可能为宫内出生(23% vs 13%;P<0.001)且患有重度 HIE(28% vs 19%;P=0.03)。早期 TT 组和晚期 TT 组在死亡或任何 NDI 的主要结局方面没有差异(调整后的 RR,1.05;95% CI,0.85-0.30;P=0.62)。在幸存者中,两组之间神经发育结局无显著差异(贝利婴幼儿发展量表 III 评分的调整平均差异:认知,-2.8 [95% CI,-6.1 至 0.5];语言,-3.3 [95% CI,-7.4 至 0.8];运动,-3.5 [95% CI,-7.3 至 0.3])。
在患有 HIE 的婴儿中,达到 TT 的时间与 2 岁时的死亡或 NDI 风险无关。在幸存者中,达到 TT 时间<4 小时和≥4 小时的婴儿之间的发育结局相似。
高剂量促红细胞生成素治疗窒息和脑病(HEAL);NCT02811263;https://beta.
gov/study/NCT02811263.